IN-HOSPITAL OUTCOME OF OCTOGENARIAN PATIENTS WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION ABSTRACT

Size: px
Start display at page:

Download "IN-HOSPITAL OUTCOME OF OCTOGENARIAN PATIENTS WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION ABSTRACT"

Transcription

1 IN-HOSPITAL OUTCOME OF OCTOGENARIAN PATIENTS WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION Nisar Ahmed, Syed Nauman Ali, Shoaib Abid ABSTRACT Background: Acute myocardial infarction (AMI) is one of e most deadly disease of e cardiovascular origen. Older patients are more likely to have a silent or unrecognized AMI and to develop heart failure, atrial fibrillation, cardiac rupture, and shock, all of which are associated wi increased mortality and a poor prognosis. Objective: To determine e frequency of in-hospital outcome of octogenarians wi acute ST segment elevation Myocardial infarction. Meodology: This cross sectional study was conducted at department of Cardiology, Chaudhary Pervaiz Elahi Institute of Cardiology, Multan from 25 October 20 to 25 April octogenarian patients of acute myocardial infarction were included in e study and clinically followed during hospital stay. The outcome variables included were mortatilty, cardiogenic shock, post MI and arrhyemia. SPSS version 20 was used for data entry and analysis. Results: was observed in 12 (.6%) of our study cases, cardiogenic shock was noted in 47 (33.6%), post MI was noted in 45 (32.1%) and arrhymia was noted in 53 (37.9%) of our study subjects. Conclusion: High frequencies of arrhymia, cardiogenic shock and post MI have been noted in elderly patients in our study. Keywords: Acute Myocardial Infarction, Octogenarian,. INTRODUCTION Myocardial infarction, is e irreversible necrosis 1 of heart muscle secondary to prolonged ischemia. Myocardial infarction is considered part of a spectrum referred to as acute coronary syndrome (ACS). The ACS continuum representing ongoing myocardial ischemia or injury consists of unstable, non ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation 2 myocardial infarction (STEMI). Wi increased life expectancy, e population of e elderly is increasing, and cardiovascular disease is e major cause of mortality and morbidity in is age 3 group. Alough age itself is a definite high risk factor in cardiovascular disease adverse outcomes, ose of extreme age are often excluded 4 from clinical trials of cardiovascular disease. However, e mechanism by which increasing age contributes to mortality remains unknown. In addition, e erapeutic strategies for elderly patients have not been well established. Alough rombolytic erapy has been shown to improve 5 survival in e elderly, but ese guidelines can be strictly applied to very elderly population is unclear, given at octogenarian patients are a very high-risk group wi a high prevalenceof co- JSZMC 20;7(1): Original Article 6 morbidities. Despite e rombolysis and percutaneous coronary intervention (PCI) technology has been developed and progressed wi stride during e past 10 years, but most cardiologist are reluctant to manage elderly patients wi ose more invasive means because of e potential 7 increased risk of dea and complications. In a study done by Yaling et al, found in-hospital mortality of 24.7%, cardiogenic shock 12.3%, arrhymias 6.2% and post-mi in 9.9% octogenarian after rombolytic erapy for acute myocardial infarction. As older age itself is a high risk for adverse outcome after any cardiac event, so is high risk group must need special attention and management plan compared to oer age groups.this study was conducted to determine e frequency of in-hospital outcome of octogenarians wi acute ST segment elevation myocardial infarction. METHODOLOGY This cross sectional study was conducted from 25 October 20 to 25 April 20. After approval from institutional eical review committee, total number of 0 patients of acute ST segment elevation myocardial infarction between 0-9 years of age 1.Department of Cardiology, Ch. Pervez Elahi Institute of Cardiology, Multan, University of Heal Sciences Lahore, Pakistan. Correspondence: Dr. Syed Nauman Ali, Senior Registrar Cardiology, House no. 4, Green wood lane, Shahid colony, MDA Road, Tariqabad, Multan, Pakistan. drnaumanali@yahoo.com Mobile: Received: Accepted: JSZMC Vol

2 bo sexes admitted to e Chaudhry Pervaiz Elahi Institute of Cardiology, emergency department were included. Patients excluded from study were ose wi non-st segment elevation MI, advanced heart failure, history of coronary artery bypass surgery and any contraindication to rombolytic erapy. Informed written consent was taken from each patient after explaining e meods and aims of study. All patients were given rombolytic erapy (Injection Streptokinase 1.5 million units over one hour) and each patient was monitored rough serial ECGs and echocardiography till discharge from e hospital. In hospital outcomes like mortality, cardiogenic shock, arrhymias and post-mi were noted as present or absent. Statistical analysis was performed using SPSS version Mean and standard deviation were calculated for quantitative variables like age and duration of disease. Frequency and percentages were calculated for qualitative variables like gender and in-hospital outcomes, mortality, cardiogenic shock, arrhymias and post-mi. Effect modifiers like age, gender, duration of disease, smoker, hypertension, and diabetes mellitus were controlled rough stratifications. Post-stratification Chi square was applied to see eir effects on e outcome and p value 0.05 was considered as significant. RESULTS Among e 0 study subjects, 99 (70.7%) were male and 41 (29.3%) were female. Mean age of our study cases was 3.34 ± 2.62 years (minimum age was 0 years while maximum was 9 years). Study results have also indicated at majority of our cases were in e range of age groups 0 to 5 years i.e. 120 (5.7%). Mean duration of disease was also inquired from e patients and it was 4.49 ± 2.67 hours (minimum duration was 1 hour while maximum duration of disease was 12 hours). Our study results have indicated at majority of our study subjects. i.e.94 (67.1%) presented between 1 5 hours. Smoking was noted in 62 (44.3%) of cases, hypertension was seen in 67 (47.9%) of cases, diabetes mellitus was noted in 47 (33.6%) of cases. was observed in 12 (.6%) of cases, cardiogenic shocks were noted in 47 (33.6%) of cases, post MI was noted in 45 (32.1%) of cases and arrhymia was noted in 53 (37.9%) of cases. (Table I-III ). Table I: In hospital outcome in cases (n=0) Outcome Frequency Percentage Total Total Total These in-hospital outcomes of octogenarian patients were stratified wi regards to gender, age, smoking, hypertension and diabetes mellitus. (Table II, III, IV, V, VI). Table II: Stratification of In-hospital outcome wi regards to gender(n=0) (n=12) Male (n=99) Gender Female (n=41) JSZMC Vol

3 Table III: Stratification of In-hospital outcome wi regards to age. (n=0) Table IV: Stratification of In-hospital outcome wi regards to Smoking. (n=0) Table V: Stratification of In-hospital outcome wi regards to hypertension.(n=0) (n=12) (n=12) (n=12) Age groups (In years) 0-5 (n=120) Hypertension (n=67) 6-9 (n=20) Smoking (n=62) (n=7) (n=73) Table VI: Stratification of In-hospital outcome wi regards to Diabetes. (n=0) Cardiogeni c (n=12) Diabetes DISCUSSION Wi improvements in heal care, e life expectancy of e elderly population has increased. The proportion of octogenarians in e general 9 population is expected to triple by e year Even ough octogenarians constitute an important high-risk subgroup of patients wi STEMI, ey are frequently under-represented in clinical trials, and advanced age is considered an independent risk factor for e early morbidity and mortality 10,11,12,13 associated wi PCI for STEMI. Poorer outcome is influenced not only by extensive coronary artery disease but also by more complex comorbidities. In addition, elderly patients are considered more likely an younger patients to suffer complications following revascularization 10,, procedures. Octogenarians have significant high-risk baseline demographic and clinical features, such as diabetes, hypertension, renal failure, anemia, cardiogenic shock, cognitive dysfunction, peripheral artery disease, longer door to balloon time, higher baseline brain natriuretic peptide, and higher C- reactive protein levels. Furer, elderly patients not only have preinterventional characteristics at are high risk for major cardiac events, but also have poor interventional characteristics, including tortuous peripheral arteries, more severe diffuse and calcified coronary artery disease, worse interventional success rates, and lower rates of post-procedural TIMI 3 10 blood flow and ST-segment resolution. A total of 0 octogenarians patients after acute ST segment myocardial infarction meeting inclusion JSZMC Vol

4 and exclusion criteria of is study were registered. Of ese 0 study cases, 99 (70.7%) were male. Similar findings were reported by Fan et al, who reported 4% male gender octogenarians in eir study. However, Claussen et al reported 49.6 % male gender in eir study which is quite less an our study results. Mean age of cases was 3.34 ± 2.62 years (minimum age was 0 years while maximum was 9 years). Study results have also indicated at majority of our cases were in e range of age groups 0 to 5 years i.e. 120 (5.7%). Mean duration of disease was 4.49 ± 2.67 hours. Our study results have indicated at majority of our study cases i.e. 94 (67.1%) presented between 1 5 hours. Smoking was noted in 62 (44.3%) of our study cases while Fan et al reported 35.2 % smoking among such patients. The findings of Fan et al, are similar to at of our study results. Claussen et al, reported 13.1 % smoking in eir study which is quite less an our study results. The reason for is quite low smoking rate may be due to e fact at ere were more females in eir study an male patients while our study included more male patients an female. Hypertension was seen in 67 (47.9%) of our study cases, while Fan et al, reported 52.2 % hypertension in ese cases which is similar to at of our study results. Claussen et al, reported 49.1 % hypertension which is similar to at of our findings. Diabetes mellitus was noted in 47 (33.6%) of our study cases. Fan et al, reported 19.4% diabetic patients in eir study, eir frequency of diabetes is bit lower an at of ours. Claussen et al, reported % diabetes in eir study which is less an our study results. was observed in 12 (.6%) of our study cases. Claussen et al, reported mortality in % of e study cases, Fan et al, reported mortality in 2.2% of ese cases. Yaling et al, reported mortality of 24.7% which is quite high an observed in our study. shock is a complication in approximately 5% % of patients presenting wi STEMI, and remains e leading cause of dea 10 after hospitalization. shocks were noted in 47 (33.6%) of our study cases while Yaling et al, reported cardiogenic shock in 12.3 % of ese cases. This finding was quite less an our study results. was noted in 45 (32.1%) of our study cases and Yaling et al, reported in 9.9 % of eir study cases. was noted in 53 (37.9%) of our study cases. Fan et al, reported arrhymia in 19.1 % of eir study cases, which is less an current study. Yaling et al, reported only 9.9 % arrhymia in eir study. CONCLUSION Elderly patients wi acute myocardial infarction have poor clinical outcomes, as far as, and arrhymia,mortality cardiogenic shocks and post MI are concerned. Our study results have indicated at mortality, cardiogenic shocks and post MI were significantly associated wi female gender, was significantly associated wi smoking. REFERENCES 1. Mallinson T. Myocardial Infarction: focus on first aid. Magazine.2010; (): Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al ACCF/AHA focused update incorporated into e ACCF/AHA 2007 guidelines for e management of patients wi unstable /non-st-elevation myocardial infarction: a report of e American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 61:e179 e Lo DKY, Chan CK, Wong JT, Leung KF, Yue CS. Outcomes in octogenarians undergoing percutaneous coronary Intervention. Asian J Gerontol Geriatr. 2011; 6: Lee KH, Ahn Y, Kim SS, Rhew SH, Jeong YW, Jang SY, et al. Characteristics, In-Hospital and Long-Term Clinical Outcomes of nagenarian Compared wi Octogenarian Acute Myocardial Infarction Patients. J Korean Med Sci. 20; 29 (4): O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al ACCF/AHA guideline for e management of ST-elevation myocardial infarction: a report of e American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 127 (4) : Caballero L, Ruiz-nodar JM, Marin F, Roldan V, Hurtado JA, Valencia J. Oral anticoagulation improves e prognosis of octogenarian patients wi atrial fibrillation undergoing percutaneous coronary intervention and stenting. Ageing 2013; 42: Sakai K, Nagayama S, Ihara K, Ando K, Shirai S, Kondo K, et al. Primary percutaneous coronary intervention for acute myocardial infarction in e JSZMC Vol

5 elderly aged 75 years. Caeter Cardiovasc Interv. 2012; 79: Yaling HAN, Yi LI, Quanming JING, Shouli WANG, Xiaozeng WANG. Comparison of interventional and conservative treatment on inhospital outcomes in elderly patients wi acute myocardial infarction. J Geriatr Cardiol. 2005; 2 (1): Da Costa A, Isaaz K, Faure E, Mourot S, Cerisier A, Lamoud M et al. Clinical characteristics, aetiological factors and long-term prognosis of myocardial infarction wi an absolutely normal coronary angiogram; a 3-year follow-up study of 91 patients. Eur Heart J 2001; 22: Alpert JS. Myocardial infarction wi angiographically normal coronary arteries. A personal perspective. Arch Intern Med 1994; 4: Larson DM, Menssen KM, Sharkey SW,Duval S, Schwartz RS, Harris J, et al. False-positive cardiac caeterization laboratory activation among patients wi suspected ST-segment elevation myocardial infarction. JAMA 2007; 29: Centers for Disease Control and Prevention MMWR series on public heal and aging. MMWR Morb Mortal Wkly Rep ; 52 (6): Gao L, Liu YQ, Xue Q, Feng QZ. Percutaneous coronary intervention in e elderly wi ST-segment elevation myocardial infarction. Clin Interv Aging. 20; 9: Fan G, Fu K, Jin C, Wang X, Han L, Wang H, et al. A medical costs study of older patients wi acute myocardial infarction and metabolic syndrome in hospital. Clin Interv Aging. 20; 10: Claussen PA, Abdelnoor M, Kevakkestad KM, Eritsland J, Halvorsen S. Prevalence of risk factors at presentation and early mortality in patients aged 0 years or older wi ST-segment elevation myocardial infarction. Vasc Heal Risk Manag. 20; 10: JSZMC Vol

Cardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008.

Cardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008. Cardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008. ST Elevation Myocardial Infarction (STEMI)-Acute Coronary Syndrome Guidelines:

More information

OP Chest Pain General Data Element List. All Records All Records. All Records All Records All Records. All Records. All Records.

OP Chest Pain General Data Element List. All Records All Records. All Records All Records All Records. All Records. All Records. Material inside brackets ([and]) is new to this Specifications Manual version. Hospital Outpatient Quality Measures Chest Pain (CP) Set Measure ID # OP-4 * OP-5 * Measure Short Name Aspirin at Arrival

More information

TAB 7: SUB TAB: AMI/CHEST PAIN Specifications & Paper Tools

TAB 7: SUB TAB: AMI/CHEST PAIN Specifications & Paper Tools TAB 7: SUB TAB: AMI/CHEST PAIN Specifications & Paper Tools Material inside brackets ([and]) is new to this Specifications Manual version. Hospital Outpatient Quality Measures Acute Myocardial Infarction

More information

Acute Coronary Syndrome. Sonny Achtchi, DO

Acute Coronary Syndrome. Sonny Achtchi, DO Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Last Updated: Version 4.4 NQF-ENORSE VOLUNTARY CONSENSUS STANARS FOR HOSPITAL CARE Measure Information Form Measure Set: Acute Myocardial Infarction (AMI) Set Measure I#: Performance Measure Name: Primary

More information

A. BISOC 1,2 A.M. PASCU 1 M. RĂDOI 1,2

A. BISOC 1,2 A.M. PASCU 1 M. RĂDOI 1,2 Bulletin of the Transilvania University of Braşov Series VI: Medical Sciences Vol. 5 (54) No. 2-2012 THE ctntg4 PLASMA LEVELS IN RELATION TO ELECTROCARDIOGRAPHIC AND ECHOCARDIOGRAPHIC ABNORMALITIES IN

More information

Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근

Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근 Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근 Case (2011, 5) 74-years old gentleman Exertional chest pain Warfarin with good INR control Ex-smoker, social(?)

More information

Early discharge in selected patients after an acute coronary syndrome can it be safe?

Early discharge in selected patients after an acute coronary syndrome can it be safe? Early discharge in selected patients after an acute coronary syndrome can it be safe? Glória Abreu, Pedro Azevedo, Carina Arantes, Catarina Quina-Rodrigues, Sara Fonseca, Juliana Martins, Catarina Vieira,

More information

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA Dr Lincoff is an interventional cardiologist and the Vice Chairman for Research

More information

PROMUS Element Experience In AMC

PROMUS Element Experience In AMC Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical

More information

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National

More information

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Trends of acute myocardial infarction in Korea from the experience of Korea Acute

More information

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang

More information

ACUTE CORONARY SYNDROME PCI IN THE ELDERLY

ACUTE CORONARY SYNDROME PCI IN THE ELDERLY ACUTE CORONARY SYNDROME PCI IN THE ELDERLY G.KARABELA MD.PhD ATHENS NAVAL HOSPITAL INTERVENTIONAL CARDIOLOGY DEPARTMENT NO CONFLICT OF INTEREST TO DECLAIRE Risk stratification in Αcute Coronary Syndrome.

More information

CMS53/AMI 8a: Primary PCI Received Within 90 Minutes of Hospital Arrival

CMS53/AMI 8a: Primary PCI Received Within 90 Minutes of Hospital Arrival PIONEERS IN QUALITY: EXPERT TO EXPERT CMS53/AMI 8a: Primary PCI Received Within 90 Minutes of Hospital Arrival Bob Dickerson, RRT, MHSA, Telligen Lynn Perrine, MSN, RN, Lantana Consulting Group Angela

More information

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case History A 50-year-old man with type 1 diabetes mellitus and hypertension presents after experiencing 1 hour of midsternal chest pain that began after

More information

OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION

OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION FEROZ MEMON*, LIAQUAT CHEEMA**, NAND LAL RATHI***, RAJ KUMAR***, NAZIR AHMED MEMON**** OBJECTIVE: To compare morbidity,

More information

1. Diabetes mellitus (DM) is associated with worse clinical and angiographic outcomes even in acute myocardial Infarction (AMI) patients.

1. Diabetes mellitus (DM) is associated with worse clinical and angiographic outcomes even in acute myocardial Infarction (AMI) patients. Midterm Clinical Outcomes of Insulin Requiring Diabetes Mellitus versus Non-insulin Dependent Diabetes Mellitus in Acute Myocardial Infarction Patients in Drug Eluting Stent Era : Insight from Korea Acute

More information

Alex versus Xience Registry Preliminary report

Alex versus Xience Registry Preliminary report Interventional Cardiology Network Alex versus Xience Preliminary report Mariusz Gąsior 1,2, Marek Gierlotka 1, Lech Poloński 1,2 1 3rd Department of Cardiology, Medical University of Silesia Centre tor

More information

Novel Risk Markers in ACS (Hyperglycemia, Anemia, GFR)

Novel Risk Markers in ACS (Hyperglycemia, Anemia, GFR) Novel Risk Markers in ACS (Hyperglycemia, Anemia, GFR) Shaul Atar, MD Department of Cardiology Faculty of Medicine of the Galilee Western Galilee Medical Center, Nahariya, Israel TIMI Risk Score Age 65

More information

What do the guidelines say?

What do the guidelines say? Percutaneous coronary intervention in 3-vessel disease and main stem What do the guidelines say? Nothing to disclose Dariusz Dudek Institute of Cardiology, Jagiellonian University Krakow, Poland The European

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

FastTest. You ve read the book now test yourself

FastTest. You ve read the book now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to

More information

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines)

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines) Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines) Authors: Dr. M. Love, Dr. I. Bata, K. Harrigan

More information

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium Risk Stratification of ACS Patients Frans Van de Werf, MD, PhD University of Leuven, Belgium Which type of ACS patients are we talking about to day? 4/14/2011 STEMI and NSTEMI in the NRMI registry from

More information

Preliminary Programme

Preliminary Programme Preliminary Programme The scientific programme comprises various styles of presentations and sessions, each offering a unique opportunity to amass new and important scientific information. Optimal management

More information

Essam Mahfouz, MD. Professor of Cardiology, Mansoura University

Essam Mahfouz, MD. Professor of Cardiology, Mansoura University By Essam Mahfouz, MD. Professor of Cardiology, Mansoura University Agenda Definitions Classifications Epidemiology Risk stratification What is new? What is MI? Myocardial infarction is the death of part

More information

1. Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study Hsieh, B.P., et al. Am

More information

Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction

Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction Sungmin Lim, Yoon Seok Koh, Hee Yeol Kim, Ik Jun Choi, Eun Ho Choo, Jin Jin Kim, Mineok

More information

ST Elevated Myocardial Infarction- Latest AHA recommendations

ST Elevated Myocardial Infarction- Latest AHA recommendations ST Elevated Myocardial Infarction- Latest AHA recommendations Sherry Turner, DO, MPH, FACOEP Medical Director Emergency Services Wesley Medical Center The Problem 250,000 Americans each year 30% fail to

More information

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines)

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines) Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines) Authors: Dr. M. Love, Dr. I. Bata, K. Harrigan

More information

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN Objectives Gain competence in evaluating chest pain Recognize features of moderate risk unstable angina Review initial management of UA and

More information

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor 76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class

More information

Objectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start?

Objectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start? Objectives Acute Coronary Syndromes; The Nuts and Bolts Michael P. Gulseth, Pharm. D., BCPS Pharmacotherapy II Spring 2006 Compare and contrast pathophysiology of unstable angina (UA), non-st segment elevation

More information

INTRODUCTION. Key Words:

INTRODUCTION. Key Words: Original Article Acta Cardiol Sin 2017;33:598 604 doi: 10.6515/ACS20170723A Coronary Artery Disease The Value of CHA 2 DS 2 VASC Score in Predicting All-Cause Mortality in Patients with ST-Segment Elevation

More information

Out-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland

Out-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland Out-of-hospital Cardiac Arrest Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland Conflict of Interest I have no conflict of interest to disclose regarding this presentation.

More information

Acute Coronary Syndromes

Acute Coronary Syndromes Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management

More information

Daily practice of ACS management in the Gulf: Data from Gulf COAST

Daily practice of ACS management in the Gulf: Data from Gulf COAST Daily practice of ACS management in the Gulf: Data from Gulf COAST Mohammad Zubaid, MB, ChB, FRCPC, FACC Professor of Medicine, Kuwait University Head, Division of Cardiology Mubarak Alkabeer Hospital

More information

CARDIOLOGY GRAND ROUNDS

CARDIOLOGY GRAND ROUNDS CARDIOLOGY GRAND ROUNDS Presentation: Date: Location: Speaker: ACC 2015 PREVIEW Monday, March 9, 2015, 7:00 8:00 AM ANW Education Building, Watson Room Elevated Troponin in Patients Presenting to the Emergency

More information

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options?

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? European Society of Cardiology Annual Session 2009 Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? Antonio Abbate, MD Assistant Professor of Medicine Virginia Commonwealth

More information

The MAIN-COMPARE Study

The MAIN-COMPARE Study Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

Experience of Korea Acute Myocardial Infarction Registry (KAMIR)

Experience of Korea Acute Myocardial Infarction Registry (KAMIR) Japan-Korea Joint AMI Symposium Korean Society of Myocardial Infarction Apr 18-19 2014 Experience of Korea Acute Myocardial Infarction Registry (KAMIR) Myung Ho Jeong, MD, PhD, FACC, FAHA, FESC, FSCAI,

More information

Measuring Natriuretic Peptides in Acute Coronary Syndromes

Measuring Natriuretic Peptides in Acute Coronary Syndromes Measuring Natriuretic Peptides in Acute Coronary Syndromes Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP Consultant Cardiologist Chief Academic and Scientific Officer St. John Providence Health

More information

Abstract Background: Methods: Results: Conclusions:

Abstract Background: Methods: Results: Conclusions: Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li

More information

Statin pretreatment and presentation patterns in patients with acute coronary syndromes

Statin pretreatment and presentation patterns in patients with acute coronary syndromes Brief Report Page 1 of 5 Statin pretreatment and presentation patterns in patients with acute coronary syndromes Marcelo Trivi, Ruth Henquin, Juan Costabel, Diego Conde Cardiovascular Institute of Buenos

More information

In-hospital Mortality Characteristics of Women With Acute Myocardial Infarction

In-hospital Mortality Characteristics of Women With Acute Myocardial Infarction Elmer Press Original Article In-hospital Mortality Characteristics of Women With Acute Myocardial Infarction Lea Ann Matura Abstract Background: Cardiovascular disease continues to be the leading cause

More information

Original Article. Gautam A.G 1, Bansal P 2, Chauhan R 3, Chadha V 4 NTRODUCTION

Original Article. Gautam A.G 1, Bansal P 2, Chauhan R 3, Chadha V 4 NTRODUCTION Original Article A Prospective Study To Know Socio-Demographic Profile In Patients With Acute Coronary Syndrome Admitted At A Tertiary Health Care And Teaching Hospital In Himachal Pradesh, North India

More information

Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy

Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Physician, Professor of Medicine Department of Cardiology,

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

4. Which survey program does your facility use to get your program designated by the state?

4. Which survey program does your facility use to get your program designated by the state? STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI

More information

Belinda Green, Cardiologist, SDHB, 2016

Belinda Green, Cardiologist, SDHB, 2016 Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens

More information

The MAIN-COMPARE Registry

The MAIN-COMPARE Registry Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

The PAIN Pathway for the Management of Acute Coronary Syndrome

The PAIN Pathway for the Management of Acute Coronary Syndrome 2 The PAIN Pathway for the Management of Acute Coronary Syndrome Eyal Herzog, Emad Aziz, and Mun K. Hong Acute coronary syndrome (ACS) subsumes a spectrum of clinical entities, ranging from unstable angina

More information

Li Xu 1, MD, Hao Sun 1, MD, Le-Feng Wang 1, MD, Xin-Chun Yang 1, MD, Kui-Bao Li 1, MD, Da-Peng Zhang 1, MD, Hong-Shi Wang 1, MD, Wei-Ming Li 1, MD

Li Xu 1, MD, Hao Sun 1, MD, Le-Feng Wang 1, MD, Xin-Chun Yang 1, MD, Kui-Bao Li 1, MD, Da-Peng Zhang 1, MD, Hong-Shi Wang 1, MD, Wei-Ming Li 1, MD Singapore Med J 2016; 57(7): 396-400 doi: 10.11622/smedj.2016121 Long-term prognosis of patients with acute myocardial infarction due to unprotected left main coronary artery disease: a single-centre experience

More information

Successful Percutaneous Coronary Intervention in a Centenarian Patient With Acute Myocardial Infarction

Successful Percutaneous Coronary Intervention in a Centenarian Patient With Acute Myocardial Infarction Case Report Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Successful Percutaneous Coronary Intervention in a Centenarian Patient With Acute Myocardial Infarction Ki Hong Lee, MD,

More information

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko,

More information

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,

More information

Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies

Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies Mohammad Zubaid, MB, ChB, FRCPC, FACC Professor of Medicine, Kuwait University Chairman, Faculty of Cardiology,

More information

Factors Associated with In-hospital Mortality in Patients with Acute Coronary Syndrome

Factors Associated with In-hospital Mortality in Patients with Acute Coronary Syndrome Journal of Cardiovascular Emergencies 2015;1(2):68-74 DOI: 10.1515/jce-2015-0010 JOURNAL OF CARDIOVASCULAR EMERGENCIES ORIGINAL RESEARCH Factors Associated with In-hospital Mortality in Patients with Acute

More information

2010 ACLS Guidelines. Primary goals of therapy for patients

2010 ACLS Guidelines. Primary goals of therapy for patients 2010 ACLS Guidelines Part 10: Acute Coronary Syndrome Present : 內科 R1 鍾伯欣 Supervisor: F1 吳亮廷 991110 Primary goals of therapy for patients of ACS Reduce the amount of myocardial necrosis that occurs in

More information

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main

More information

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST DECLARATION OF CONFLICT OF INTEREST Multivessel disease and cardiogenic shock: CABG is the optimal revascularization therapy. Contra Prof. Christian JM Vrints Cardiogenic Shock Spiral Acute Myocardial

More information

Transfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem

Transfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem Transfer in D2B Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland The Problem NRMI-5: North Carolina, July 2003- June 2004 NC Nation Guidelines N 2,738 79,927

More information

Continuing Medical Education Post-Test

Continuing Medical Education Post-Test Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on

More information

Original Article. Abstract

Original Article. Abstract In-hospital and six-month outcomes of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction Abstract Fereydoon Noohi (1), Isa Hashemi (2),

More information

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Percutaneous Coronary Interventions Without On-site Cardiac Surgery Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European

More information

Coronary Catheterization and Percutaneous Coronary Intervention in China 10-Year Results From the China PEACE-Retrospective CathPCI Study

Coronary Catheterization and Percutaneous Coronary Intervention in China 10-Year Results From the China PEACE-Retrospective CathPCI Study Coronary Catheterization and Percutaneous Coronary Intervention in China 10-Year Results From the China PEACE-Retrospective CathPCI Study Xin Zheng, MD, PhD; Jeptha P. Curtis, MD; Shuang Hu, PhD; YongfeiWang,

More information

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the

More information

APPENDIX F: CASE REPORT FORM

APPENDIX F: CASE REPORT FORM APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more

More information

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in

More information

Exhibit EP16.h University of Virginia Medical Center Clinical Decision Tool

Exhibit EP16.h University of Virginia Medical Center Clinical Decision Tool TITLE: Emergency Management for Suspicion of Cardiac Event PURPOSE: Increasingly, patients have multiple morbidities and are at risk of adverse events related or unrelated to the condition for which they

More information

Background- Methods-

Background- Methods- ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE- Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data Jing Li, Xi Li, Qing

More information

Mode of admission and its effect on quality indicators in Belgian STEMI patients

Mode of admission and its effect on quality indicators in Belgian STEMI patients 2015 Mode of admission and its effect on quality indicators in Belgian STEMI patients Prof dr M Claeys National Coordinator STEMI registry 29-6-2015 Background The current guidelines for the management

More information

Pathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL

Pathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL Pathology of percutaneous interventions (PCI) in coronary arteries Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL Percutaneous Coronary Intervention (PCI) Definition: transcatheter opening of

More information

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Acute Myocardial Infarction. Willis E. Godin D.O., FACC Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable

More information

Adults With Diagnosed Diabetes

Adults With Diagnosed Diabetes Adults With Diagnosed Diabetes 1990 No data available Less than 4% 4%-6% Above 6% Mokdad AH, et al. Diabetes Care. 2000;23(9):1278-1283. Adults With Diagnosed Diabetes 2000 4%-6% Above 6% Mokdad AH, et

More information

Early treatment with high-potency statins in patients with acute coronary syndrome an example of personalized medicine

Early treatment with high-potency statins in patients with acute coronary syndrome an example of personalized medicine Editorial Early treatment with high-potency statins in patients with acute coronary syndrome an example of personalized medicine Emanuel Harari, Alon Eisen Cardiology Department, Rabin Medical Center,

More information

CURRICULUM VITAE Shanshan Zhou. Shanshan Zhou. Department of Cardiology. Tel: Feb 25, 1982, China. Chinese.

CURRICULUM VITAE Shanshan Zhou. Shanshan Zhou. Department of Cardiology. Tel: Feb 25, 1982, China. Chinese. CURRICULUM VITAE Shanshan Zhou PERSONAL DETAILS Name: Work address: Shanshan Zhou Department of Cardiology The General Hospital of the People's Liberation Army 28 Fuxing Road, Haidian District, Beijing,

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis

More information

Quale terapia antiaggregante nello STEMI? Prasugrel vs ticagrelor

Quale terapia antiaggregante nello STEMI? Prasugrel vs ticagrelor Quale terapia antiaggregante nello STEMI? Prasugrel vs ticagrelor Leonardo Bolognese Cardiovascular Department, Arezzo, Italy Platelet Reactivity in Patients with STEMI Undergoing Primary PCI Campo G et

More information

Cardiogenic Shock. Carlos Cafri,, MD

Cardiogenic Shock. Carlos Cafri,, MD Cardiogenic Shock Carlos Cafri,, MD SHOCK= Inadequate Tissue Mechanisms: Perfusion Inadequate oxygen delivery Release of inflammatory mediators Further microvascular changes, compromised blood flow and

More information

form of ACS, accounting for 25%-40% of MI presentations with in-hospital mortality of 5%-6% in the developed countries. 5

form of ACS, accounting for 25%-40% of MI presentations with in-hospital mortality of 5%-6% in the developed countries. 5 The Professional Medical Journal DOI: 10.29309/TPMJ/18.4763 ORIGINAL PROF-4763 ACUTE ST ELEVATION MYOCARDIAL INFARCTION; 70 % OR MORE ST SEGMENT RESOLUTION ON 90 MINUTES POST THROMBOLYSIS ELECTROCARDIOGRAM

More information

BEDSIDE ASSESSMENT OF PATIENTS WITH STEMI

BEDSIDE ASSESSMENT OF PATIENTS WITH STEMI BEDSIDE ASSESSMENT OF PATIENTS WITH STEMI Prof. Maria Dorobantu, PhD, FESC, FACC Emergency Hospital of Bucharest, Romania Presenter Disclosures There are no conflicts/ grants/ disclosures for this presentation.

More information

Learning Objectives. Epidemiology of Acute Coronary Syndrome

Learning Objectives. Epidemiology of Acute Coronary Syndrome Cardiovascular Update: Antiplatelet therapy in acute coronary syndromes PHILLIP WEEKS, PHARM.D., BCPS-AQ CARDIOLOGY Learning Objectives Interpret guidelines as they relate to constructing an antiplatelet

More information

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center Aging Research Volume 2013, Article ID 471026, 4 pages http://dx.doi.org/10.1155/2013/471026 Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at

More information

Approach to Multi Vessel disease with STEMI

Approach to Multi Vessel disease with STEMI Approach to Multi Vessel disease with STEMI MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION Dr. Thomas Alexander, M.D; D.M; F.A.C.C. Senior Consultant and Interventional Cardiologist Kovai Medical Centre

More information

Mortality following acute myocardial infarction (AMI) in

Mortality following acute myocardial infarction (AMI) in In-Hospital Mortality Among Patients With Type 2 Diabetes Mellitus and Acute Myocardial Infarction: Results From the National Inpatient Sample, 2000 2010 Bina Ahmed, MD; Herbert T. Davis, PhD; Warren K.

More information

Acute Coronary Syndromes: Challenges to Management. Claire Williams November 2017

Acute Coronary Syndromes: Challenges to Management. Claire Williams November 2017 Acute Coronary Syndromes: Challenges to Management Claire Williams November 2017 Challenge 1: Diagnosis Chest pain >20 minutes ECG Challenge 1: Diagnosis Treat as STEMI Chest pain >20 minutes ECG STEMI

More information

Dual Antiplatelet Therapy Made Practical

Dual Antiplatelet Therapy Made Practical Dual Antiplatelet Therapy Made Practical David Parra, Pharm.D., FCCP, BCPS Clinical Pharmacy Program Manager in Cardiology/Anticoagulation VISN 8 Pharmacy Benefits Management Clinical Associate Professor

More information

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 INTRODUCTION The clinical entities that comprise acute coronary syndromes (ACS)-ST-segment

More information

LM stenting - Cypher

LM stenting - Cypher LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with

More information

Non ST Elevation-ACS. Michael W. Cammarata, MD

Non ST Elevation-ACS. Michael W. Cammarata, MD Non ST Elevation-ACS Michael W. Cammarata, MD Case Presentation 65 year old man PMH: CAD s/p stent in 2008 HTN HLD Presents with chest pressure, substernally and radiating to the left arm and jaw, similar

More information

GENDER DIFFERENCES OF STENT IMPLANTATION COMPLICATIONS. ASSESSMENT OF ACUTE CORONARY SYNDROME WITH ST ELEVATION

GENDER DIFFERENCES OF STENT IMPLANTATION COMPLICATIONS. ASSESSMENT OF ACUTE CORONARY SYNDROME WITH ST ELEVATION GENDER DIFFERENCES OF STENT IMPLANTATION COMPLICATIONS. ASSESSMENT OF ACUTE CORONARY SYNDROME WITH ST ELEVATION Lali Gujejiani, PhD Student Nino Sharashidze, Full Prof. Ivane Javakhishvili Tbilisi State

More information

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Gamal Abdelhady, Emad Mahmoud Department of interventional

More information

Subsequent management and therapies

Subsequent management and therapies ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Subsequent management and therapies Marco Valgimigli, MD, PhD University of Ferrara ITALY

More information

Chest Pain. Dr Robert Huggett Consultant Cardiologist

Chest Pain. Dr Robert Huggett Consultant Cardiologist Chest Pain Dr Robert Huggett Consultant Cardiologist Outline Diagnosis of cardiac chest pain 2016 NICE update on stable chest pain Assessment of unstable chest pain/acs and MI definition Scope of the

More information

Improving the Outcomes of

Improving the Outcomes of Improving the Outcomes of STEMI Shelley Valaire, ACP; and Robert Welsh, MD, FRCPC Presented at the University of Alberta s 6th Annual Cardiology Update for General Practitioners and Internists, Edmonton,

More information

Lack of Effect of Beta-blocker Therapy in Patients with ST-elevation Acute Myocardial Infarction in PCI Era

Lack of Effect of Beta-blocker Therapy in Patients with ST-elevation Acute Myocardial Infarction in PCI Era Lack of Effect of Beta-blocker Therapy in Patients with ST-elevation Acute Myocardial Infarction in PCI Era B. Bao 1, N. Ozasa 1, T. Morimoto 2, Y. Furukawa 3, M. Shirotani 4, H. Ogawa 5, C. Tei 6, H.

More information